Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/28/16
End: 01/23/17
Due: 01/23/18
Phase: N/A
Priority: Normal
Start: 01/02/19
End: 12/31/19
Due: 12/31/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients | NCT03094845 | ASIT Biotech S.A. | user2@example.com | None | 2016-09-28 | 2017-01-23 | 2018-01-23 | - | - | 2025-07-14 |
| Clinical Efficacy and Safety of Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis | NCT03724240 | ASIT Biotech S.A. | user2@example.com | None | 2019-01-02 | 2019-12-31 | 2020-12-31 | - | - | 2025-07-14 |